BLEG (Branded Legacy) Short-Term Debt: $0.00 Mil (As of Dec. 2021)


What is Branded Legacy Short-Term Debt?

Branded Legacy BLEG Short-Term Debt is $0.00 Mil as of Dec. 2021.

Branded Legacy's Short-Term Debt for the quarter that ended in Dec. 2021 was $0.00 Mil.

Branded Legacy Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Branded Legacy Short-Term Debt Related Terms

Branded Legacy Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Branded Legacy's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy Short-Term Debt Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Short-Term Debt
Get a 7-Day Free Trial 0.13 0.03 0.00 0.00 0.00

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.00 Mil mean?
Branded Legacy (BLEG) has a Short-Term Debt of $0.00 Mil as of Dec. 2021.
Is Branded Legacy's Short-Term Debt too high?
Branded Legacy's current Short-Term Debt is $0.00 Mil.
How does Branded Legacy's Short-Term Debt compare to UPDC and RIBT?
Branded Legacy's Short-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Branded Legacy's current Short-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEG) has a current Short-Term Debt of $0.00 Mil. The current Short-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Branded Legacy (BLEG), the current Short-Term Debt is $0.00 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.